Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-MO)

American Journal of Clinical Pathology

Volumn 113, Issue 2, 2000, Pages 193-200

  Kotylo, Patricia K ^a,d   Seo, In Sook ^a   Smith, Franklin O ^a   Heerema, Nyla A ^a   Fineberg, Naomi S ^a   Miller, Kathy ^a   Greene, Marianne E ^b   Chou, Pauline ^b   Orazi, Attilio ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c Coll Phys Surgs of Columbia Univ ^*  (United States)

^d RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Adult; Immunophenotyping; Minimally differentiated acute myeloid leukemia; Pediatric

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; POLYCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST TRANSFORMATION; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CYTOCHEMISTRY; EMBEDDING; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0033996497     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/2fyj-00be-r8n0-hmpq     Document Type: Article

References (26)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol. 1991;78:325-329.
2. Foucar K. Bone Marrow Pathology. Chicago, IL: ASCP Press; 1995:193-194.
3. Orazi A, Cattoretti G, Schiro R, et al. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in-vivo after high dose cyclophosphamide cancer-chemotherapy: eftect on the hematopoiesis and micro environment in the human hone marrow. Blood. 1992;79:2610-2619.
4. Pinkus G, Pinkus J. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol. 1991;4:733-741.
5. Borowitz MJ, Guenther KL, Shultz KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
6. Carey JL, Hanson CA. Flow cytometric analysis of leukemia. In: Keren DF, Hanson CA, Hurtubise PE, eds. Flow Cytometry and Clinical Diagnosis. Chicago, IL: ASCP Press; 1994:197-203.
7. Mitelman F, ed. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 1995.
8. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, CA: Lifetime Learning Publications; 1980:129-130, 299-333.
9. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis ot hematologic malignancy. Blood. 1997;90:2863-2892.
10. van't Veer MB. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Ann Hematol. 1992;64:161-165.
11. Sempere A, Jarque I, Guinot M, et al. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases. Leuk Lymphoma. 1993;12:103-108.
12. Vendetti A, del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.
13. Cohen P, Hoyer J, Kurtin P, et al. Acute myeloid leukemia with minimal differentiation: a multiple parameter study. Am J Clin Pathol. 1998;109:32-38.
14. Praxedes MK, De Oliveira LZ, Pereira WD, et al. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukemia. Leuk Lymphoma. 1994;12:233-239.
15. Brito-Babapulle F, Pullon H, Layton DM, et al. Clinicopathologic features of acute undifterentiated leukaemia with a stem cell phenotype. Br J Haematol. 1990;76:210-214.
16. Campos L, Guyotat D, Archimbaud E, et al. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol. 1989;72:161-166.
17. Khalidi H, Medeiros J, Chang KL, et al. The immunophenotype ot adult acute myeloid leukemia: high frequency ot lymphoid antigen expression and comparison ot immunophenotype, French-American-British classification, and karyotype abnormalities. Am J Clin Pathol. 1998;109:211-220.
18. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood. 1991;77:2242-2250.
19. Arber DA, Jenkins, KA. Paraffin section immunophenotyping ot acute leukemias in bone marrow specimens. Am J Clin Patho. 1996;106:462-468.
20. Vander Schoot CE, Daams GM, Pinkster J, et al. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukemia. Br J Haematol. 1990;74:173-178.
21. Wang JC, Beauregard P, Soamboonsrup P, et al. Monoclonal antibodies in management of acute leukemia. Am J Hematol. 1995;50:188-199.
22. Matutes E, de Oliveira MP, Foron L, et al. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukemia. Br J Haematol. 1988;69:205-211.
23. Pedersen B, Jensen IM. Trisomy 13: a preferentially male chromosome aberration interfering specifically with myeloid proliferation and differentiation? report of a case and review of the literature. Cancer Genet Cytogenet. 1991;57:79-85.
24. Sreekantaiah C, Baer MR, Morgan S, et al. Trisomy/tetrasomy 13 in seven cases of acute leukemia. Leukemia. 1990;4:781-785.
25. Cuneo A, Ferrant A, Michaux JL, et al. Cytogenetic profile of minimally differentiated (FAB-M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood. 1995;85:3688-3694.
26. Stasi R, Del Poeta G, Vendetti A, et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood. 1994;83:1619-1625.